Artificial Intelligence Based Multimodality Imaging: A New Frontier in Coronary Artery Disease Management

Area of Science:

• Cardiovascular Imaging
• Artificial Intelligence in Medicine
• Ischemic Heart Disease

Background:

• Coronary artery disease (CAD) is a leading global cause of mortality.
• Multimodality imaging is crucial for diagnosing and stratifying CAD risk.
• Coronary Computed Tomography Angiography (CCTA) is increasingly vital for ruling out CAD.

Purpose of the Study:

• To provide a comprehensive overview of current and future artificial intelligence (AI) applications in multimodality imaging for ischemic heart disease.
• To explore AI's role in improving the efficiency, reliability, and sustainability of cardiac imaging modalities.

Main Methods:

• Review of current and emerging AI applications across various cardiac imaging techniques, including echocardiography, CCTA, cardiac magnetic resonance, and nuclear imaging.
• Analysis of AI's potential to identify subtle predictors of adverse outcomes from large datasets ('big data').

Main Results:

• AI is poised to play a pivotal role in enhancing echocardiography, CCTA, cardiac MRI, and nuclear imaging for CAD.
• AI algorithms can improve diagnostic accuracy and risk stratification in patients with suspected or established CAD.
• AI can assist in detecting early adverse outcome predictors often missed by human analysis.

Conclusions:

• AI integration into multimodality imaging is essential for advancing the management of ischemic heart disease.
• AI offers significant potential to make cardiac imaging more efficient, reliable, and cost-effective.
• Future AI applications will be fundamental in optimizing patient care for CAD.